Tumor immune surveillance of NK cells is mediated by cytotoxicity receptor natural-killer group 2 member D (NKG2D), whose ligand NKG2D-ligand is not normally expressed in healthy cells. The gene discussed is KLRK1; the disease is neoplasm.